Deep brain stimulation for the treatment of refractory and super-refractory status epilepticus

Status epilepticus (SE) is a life-threatening medical emergency, even if appropriate treatment is initiated, the mortality within 30 days ranges from 10 % to 30 % [1]. The mortality rates of convulsive SE are even higher – up to 39 % in population-based studies [2]. The data regarding the outcome for nonconvulsive SE (NCSE) are sparse [3]. The clinical and EEG definitions of NCSE have changed over time, but they have been updated recently in the Salzburg consensus criteria for NCSE with an approach to clinical application [4–6].